D-Bio Connect

Main business of D-Bio Connect is the D-Bio Connect Biz Meeting Categorized by Target Diseases half a year. D-Bio Connect collects research results, evaluates them, advises to make materials used in D-Bio Connect, arranges meetings, feedbacks the company’s plan after the meeting, and supports an agreement of research collaboration.

To collect research results of drug discovery by searching researcher’s presentation in exhibitions, introduction from research institute, news release, and patents.
These research results are accumulated by disease in the D-Bio Connect-DB.

The D-Bio Connect administrator selects research results in the D-Bio Connect-DB for the D-Bio Connect Biz Meeting Categorized by Target Diseases under the requirements. This selection requirements are set by disease on the basis of the pharmaceutical companies’ needs.

When your research results in the D-Bio Connect-DB are invited to the D-Bio Connect Biz Meeting, D-Bio Connect will advise to make your materials provided for pharmaceutical companies.
This enables you to efficiently have a discussion toward a research collaboration by using these materials on the day of meeting.

The D-Bio Connect administrator captures participants’ needs and tries to do best so that all participants can hold efficient meetings toward a research collaboration.

In place of pharmaceutical companies, the D-Bio Connect administrator gives researchers feedback about decision.
D-Bio Connect will also confirm the research progress afterward.

If the contract is concluded smoothly by D-Bio Connect’s supports, the D-Bio Connect administrator supports to make contractual conditions after the framework of joint research is almost decided,

The D-Bio Connect administrator has accumulated know-how regarding a process to joint research. It is utilized in the next cycle.